NASDAQ:NRAC

Noble Rock Acquisition Competitors

Notice: This company has been marked as potentially delisted and may not be actively trading.
$9.70
-0.06 (-0.61 %)
(As of 05/4/2021 04:00 PM ET)
Add
Compare
Today's Range
$9.70
$9.72
50-Day Range N/A
52-Week Range
$9.60
$10.00
Volume28,250 shs
Average Volume106,571 shs
Market Capitalization$70.51 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Noble Rock Acquisition (NASDAQ:NRAC) Vs. ARBG, EAC, SHAC, BIOT, OSTR, and VIH

Should you be buying NRAC stock or one of its competitors? Companies in the industry of "shell companies" are considered alternatives and competitors to Noble Rock Acquisition, including Aequi Acquisition (ARBG), Edify Acquisition (EAC), SCP & CO Healthcare Acquisition (SHAC), Biotech Acquisition (BIOT), Oyster Enterprises Acquisition (OSTR), and VPC Impact Acquisition (VIH).

Aequi Acquisition (NASDAQ:ARBG) and Noble Rock Acquisition (NASDAQ:NRAC) are both small-cap financial services companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, risk, earnings, profitability, valuation, dividends and institutional ownership.

Valuation and Earnings

This table compares Aequi Acquisition and Noble Rock Acquisition's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aequi AcquisitionN/AN/AN/AN/AN/A
Noble Rock AcquisitionN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and target prices for Aequi Acquisition and Noble Rock Acquisition, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Aequi Acquisition0000N/A
Noble Rock Acquisition0000N/A

Profitability

This table compares Aequi Acquisition and Noble Rock Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Aequi AcquisitionN/AN/AN/A
Noble Rock AcquisitionN/AN/AN/A

Noble Rock Acquisition (NASDAQ:NRAC) and Edify Acquisition (NASDAQ:EAC) are both small-cap financial services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, valuation, dividends and analyst recommendations.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Noble Rock Acquisition and Edify Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Noble Rock Acquisition0000N/A
Edify Acquisition0000N/A

Profitability

This table compares Noble Rock Acquisition and Edify Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Noble Rock AcquisitionN/AN/AN/A
Edify AcquisitionN/AN/AN/A

Earnings and Valuation

This table compares Noble Rock Acquisition and Edify Acquisition's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Noble Rock AcquisitionN/AN/AN/AN/AN/A
Edify AcquisitionN/AN/AN/AN/AN/A

SCP & CO Healthcare Acquisition (NASDAQ:SHAC) and Noble Rock Acquisition (NASDAQ:NRAC) are both small-cap financial services companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

Analyst Recommendations

This is a summary of current recommendations for SCP & CO Healthcare Acquisition and Noble Rock Acquisition, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
SCP & CO Healthcare Acquisition0000N/A
Noble Rock Acquisition0000N/A

Valuation & Earnings

This table compares SCP & CO Healthcare Acquisition and Noble Rock Acquisition's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SCP & CO Healthcare AcquisitionN/AN/AN/AN/AN/A
Noble Rock AcquisitionN/AN/AN/AN/AN/A

Profitability

This table compares SCP & CO Healthcare Acquisition and Noble Rock Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
SCP & CO Healthcare AcquisitionN/AN/AN/A
Noble Rock AcquisitionN/AN/AN/A

Noble Rock Acquisition (NASDAQ:NRAC) and Biotech Acquisition (NASDAQ:BIOT) are both small-cap financial services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, valuation, dividends, analyst recommendations and risk.

Valuation & Earnings

This table compares Noble Rock Acquisition and Biotech Acquisition's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Noble Rock AcquisitionN/AN/AN/AN/AN/A
Biotech AcquisitionN/AN/AN/AN/AN/A

Profitability

This table compares Noble Rock Acquisition and Biotech Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Noble Rock AcquisitionN/AN/AN/A
Biotech AcquisitionN/AN/AN/A

Analyst Ratings

This is a breakdown of current recommendations for Noble Rock Acquisition and Biotech Acquisition, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Noble Rock Acquisition0000N/A
Biotech Acquisition0000N/A

Oyster Enterprises Acquisition (NASDAQ:OSTR) and Noble Rock Acquisition (NASDAQ:NRAC) are both small-cap financial services companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, risk, valuation, profitability, dividends, analyst recommendations and institutional ownership.

Profitability

This table compares Oyster Enterprises Acquisition and Noble Rock Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Oyster Enterprises AcquisitionN/AN/AN/A
Noble Rock AcquisitionN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Oyster Enterprises Acquisition and Noble Rock Acquisition, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Oyster Enterprises Acquisition0000N/A
Noble Rock Acquisition0000N/A

Earnings & Valuation

This table compares Oyster Enterprises Acquisition and Noble Rock Acquisition's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oyster Enterprises AcquisitionN/AN/AN/AN/AN/A
Noble Rock AcquisitionN/AN/AN/AN/AN/A

Noble Rock Acquisition (NASDAQ:NRAC) and VPC Impact Acquisition (NASDAQ:VIH) are both small-cap financial services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, dividends, analyst recommendations, institutional ownership, valuation and profitability.

Valuation & Earnings

This table compares Noble Rock Acquisition and VPC Impact Acquisition's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Noble Rock AcquisitionN/AN/AN/AN/AN/A
VPC Impact AcquisitionN/AN/AN/AN/AN/A

Profitability

This table compares Noble Rock Acquisition and VPC Impact Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Noble Rock AcquisitionN/AN/AN/A
VPC Impact AcquisitionN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and price targets for Noble Rock Acquisition and VPC Impact Acquisition, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Noble Rock Acquisition0000N/A
VPC Impact Acquisition0000N/A


Noble Rock Acquisition Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
ARBG
Aequi Acquisition
0.0$9.74-0.5%$281.46 millionN/A0.00
EAC
Edify Acquisition
0.0$9.69-0.0%$281.01 millionN/A0.00
SHAC
SCP & CO Healthcare Acquisition
0.0$9.77-0.4%$280.89 millionN/A0.00
BIOT
Biotech Acquisition
0.0$9.73-0.1%$279.74 millionN/A0.00
OSTR
Oyster Enterprises Acquisition
0.0$9.71-0.2%$279.16 millionN/A0.00
VIH
VPC Impact Acquisition
0.0$10.84-1.0%$278.09 millionN/A0.00
CCAC
CITIC Capital Acquisition
0.3$9.96-0.4%$276 millionN/A0.00Decrease in Short Interest
SVOK
Seven Oaks Acquisition
0.0$9.75-0.2%$274.78 millionN/A0.00
ROT
Rotor Acquisition
0.0$9.91-0.1%$273.79 millionN/A0.00
PIPP
Pine Island Acquisition
1.0$10.01-0.2%$272.72 millionN/A0.00
MTAC
MedTech Acquisition
0.0$9.70-0.8%$268.95 millionN/A0.00
Acies Acquisition logo
ACAC
Acies Acquisition
1.7$9.97-0.1%$267.98 millionN/A0.00Analyst Report
ION Acquisition Corp 1 logo
IACA
ION Acquisition Corp 1
0.0$10.05-0.1%$259.79 millionN/A0.00News Coverage
LEGO
Legato Merger
0.0$9.78-0.1%$257.95 millionN/A0.00
LFTR
Lefteris Acquisition
0.0$9.85-0.1%$255.25 millionN/A0.00
TWOA
TWO
0.0$9.91-0.2%$254.21 millionN/A0.00Quiet Period Expiration
LHAA
Lerer Hippeau Acquisition
0.0$9.85-1.3%$252.55 millionN/A0.00High Trading Volume
SRSA
Sarissa Capital Acquisition
0.0$10.07-0.5%$251.75 millionN/A0.00High Trading Volume
CPUH
Compute Health Acquisition
0.0$9.86-0.3%$247.09 millionN/A0.00
QFTA
Quantum FinTech Acquisition
0.0$9.75-0.3%$244.52 millionN/A0.00
PAQC
Provident Acquisition
0.0$9.80-0.3%$244.25 millionN/A0.00
AKIC
Sports Ventures Acquisition
0.0$9.80-0.2%$237.50 millionN/A0.00
TACA
Trepont Acquisition Corp I
0.0$9.86-1.0%$229.08 millionN/A0.00
CAS
Cascade Acquisition
0.0$9.95-0.3%$228.85 millionN/A0.00
LWAC
Locust Walk Acquisition
0.0$9.80-0.3%$221.05 millionN/A0.00
LEAP
Ribbit LEAP
0.0$11.03-0.5%$219.82 millionN/A0.00
GNRS
Greenrose Acquisition
0.0$10.00-0.0%$218.92 millionN/A0.00Increase in Short Interest
TVAC
Thayer Ventures Acquisition
0.0$10.00-0.0%$215.63 millionN/A0.00
VTAQ
Ventoux CCM Acquisition
0.0$9.99-0.0%$215.41 millionN/A0.00
EQHA
EQ Health Acquisition
0.0$9.79-0.0%$215.38 millionN/A0.00
LNFA
L&F Acquisition
0.0$9.96-0.2%$214.76 millionN/A0.00
DSAC
Duddell Street Acquisition
0.0$9.82-0.1%$214.59 millionN/A0.00
GWAC
Good Works Acquisition
0.0$10.01-0.4%$214.14 millionN/A0.00
GigCapital3 logo
GIK
GigCapital3
1.7$7.93-3.9%$213.36 millionN/A0.00Increase in Short Interest
GCAC
Growth Capital Acquisition
0.0$9.75-0.0%$210.24 millionN/A0.00
GNPK
Genesis Park Acquisition
0.3$10.04-0.5%$206.56 millionN/A0.00
OCA
Omnichannel Acquisition
0.0$9.82-0.4%$203.61 millionN/A0.00
APGB
Apollo Strategic Growth Capital II
0.0$9.88-0.1%$198.36 millionN/A0.00
BLSA
BCLS Acquisition
0.0$10.27-0.0%$188.44 millionN/A0.00
DUNE
Dune Acquisition
0.0$9.79-0.4%$184.31 millionN/A0.00
SVFA
SVF Investment
0.0$10.08-0.3%$177.79 millionN/A0.00
PIAI
Prime Impact Acquisition I
0.0$9.83-0.1%$174.21 millionN/A0.00
VCKA
Vickers Vantage Corp. I
0.0$9.94-0.1%$171.47 millionN/A0.00
HIII
Hudson Executive Investment Corp. III
0.0$9.76-0.4%$170.98 millionN/A0.00
YSAC
Yellowstone Acquisition
0.0$10.05-0.1%$170.67 millionN/A0.00
LJAQ
LightJump Acquisition
0.0$9.82-0.0%$170.57 millionN/A0.00
LMACA
Prospector Capital
0.0$10.20-0.4%$170.50 millionN/A0.00
PRPC
CC Neuberger Principal Holdings III
0.0$9.87-0.1%$166.38 millionN/A0.00
CCVI
Churchill Capital Corp VI
0.0$10.03-0.5%$160.09 millionN/A0.00
SGAM
Seaport Global Acquisition
0.3$9.89-0.1%$154.53 millionN/A0.00
This page was last updated on 5/5/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.